Advanced Search

 

Study ID Status Title Patient Level Data
112264 Completed Study NOG112264, a Phase II Study of Ozanezumab (GSK1223249) versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
112266 Completed An open single centre study to evaluate the long-term antibody persistence and immune memory between 16 and 20 years after the primary study HAB-032 (208127/022) in which healthy adults were vaccinated with Twinrix Adult following a three-dose schedule.
112267 Completed An open single centre study to evaluate the long-term antibody persistence and immune memory between 16 and 20 years after the primary study HAB-028 (208127/021) in which healthy adults were vaccinated with Twinrix Adult following a three-dose schedule.
112269 Completed Immunogenicity, reactogenicity and safety study to evaluate two doses of the lyophilised formulation of the human rotavirus (HRV) vaccine when administered to healthy Korean infants previously uninfected with HRV Study Listed on ClinicalStudyDataRequest.com
112276 Completed A Phase IIb study to select a once daily dose of GSK1349572 administered with either abacavir/lamivudine or tenofovir/emtricitabine in HIV-1 infected antiretroviral therapy naive adult subjects
112277 Completed Drug Use Investigation for ADOAIR (fluticasone/salmeterol)
112278 Active, Not Recruiting Special Drug Use Investigation for ADOAIR (fluticasone/salmeterol)
112279 Active, Not Recruiting Drug Use Investigation for ARRANON G (nelarabine) Injection 250mg
112279 Active, Not Recruiting Drug Use Investigation for ARRANON G (nelarabine) Injection 250mg
112280 Completed Drug Use Investigation for ALKERAN (melphalan) Injection 50mg
112281 Completed Special Drug Use Investigation for Clavamox pediatrics Drug Syrup (otitis media)
112282 Completed Special Drug Use Investigation for ALKERAN (melphalan) Injection 50mg (5-year survival ratio)
112283 Completed Special Drug Use Investigation for CLAVAMOX® (amoxicillin/clavulanate) Pediatrics Dry Syrup (every indication excluded otitis media)
112284 Completed Special Drug Use Investigation for Fultide (Long-term:drypowder)
112285 Completed Special Drug Use Investigation for ARIXTRA® Injection
112286 Completed Special Drug Use Investigation for Botox injection (blepharospasm)
112287 Completed Drug Use Investigation for Combivir tablet (HRD Cooperative Investigation)
112288 Completed Special Drug Use Investigation for Fultide (Long-term:aerosol)
112289 Completed Drug Use Investigation for Botox® Injection (spasmodic torticollis)
112290 Completed Special Drug Use Investigation for Combivir tablet (Pregnancy) (HRD Cooperative Investigation)
112291 Completed Special Drug Use Investigation for Fultide (Hospitalised asthma)
112292 Completed Drug Use Investigation for Botox injection (hemi-prosopospasm)
112293 Completed Drug Use Investigation for Eskazole tablet
112294 Completed Drug Use Investigation for Fultide (Pediatrics)
112295 Completed Drug Use Investigation for Epivir tablet (HRD Cooperative Investigation)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.